Delic Survey Shows Americans With Mental Health Conditions Are Ready For Access To Psychedelics Jan 20, 2022
Revitalist Provides Summary of 2021, Reporting Patient Visits of 5,000, a 128% Increase From 2020 Jan 20, 2022
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial Jan 19, 2022
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Jan 19, 2022
Two Thirds Of Physicians Surveyed Believe Psilocybin Therapy Has Potential Benefit For Patients With Treatment-Resistant… Jan 19, 2022
